Ecological Study on Hospitalizations for Cancer, Cardiovascular, and Respiratory Diseases in the Industrial Area of Etang-de-Berre in the South of France

Table 6

RR of cardiovascular, respiratory and cancer hospitalizations and 95% credible interval (CI) in adults.

Hospitalizations indicators	Exposure class	Males		Females
		RR	CI 95%	RR	CI 95%
All cardiovascular diseases	Reference	1		1
	Medium	1.03	[0.95–1.11]	1.01	[0.90–1.12]
	High	0.96	[0.88–1.05]	0.91	[0.80–1.04]
Heart diseases	Reference	1		1
	Medium	1.08	[0.97–1.19]	1.13	[0.96–1.32]
	High	0.98	[0.87–1.11]	0.99	[0.82–1.19]
Coronary heart diseases	Reference	1		1
	Medium	1.13	[0.93–1.36]	1.22	[0.87–1.65]
	High	1.07	[0.86–1.34]	1.11	[0.76–1.61]
Myocardial infarction	Reference	1		1
	Medium	1.13	[0.94–1.37]	1.38	[1.04–1.83]
	High	1.26	[1.02–1.57]	1.54	[1.14–2.10]
Heart rate disorders	Reference	1		1
	Medium	1.15	[0.98–1.35]	1.01	[0.81–1.31]
	High	1.16	[0.98–1.40]	1.05	[0.80–1.40]
Coronary heart diseases with heart rate disorders	Reference	1		1
	Medium	0.94	[0.73–1.20]	1.06	[0.76–1.47]
	High	1.05	[0.73–1.52]	0.90	[0.61–1.31]
Stroke	Reference	1		1
	Medium	0.97	[0.80–1.19]	1.07	[0.82–1.37]
	High	1.07	[0.86–1.34]	0.86	[0.60–1.15]
All respiratory diseases	Reference	1		1
	Medium	0.97	[0.84–1.10]	1.08	[0.90–1.27]
	High	1.01	[0.86–1.20]	1.05	(0.86–1.29]
Respiratory infections	Reference	1		1
	Medium	0.87	[0.68–1.11]	0.85	[0.65–1.09]
	High	1.00	[0.76–1.32]	0.97	[0.73–1.30]
Pneumonia	Reference	1		1
	Medium	0.87	[0.68–1.13]	0.80	[0.63–1.03]
	High	0.95	[0.72–1.29]	0.93	[0.69–1.24]
Acute COPD	Reference	1		1
	Medium	0.87	[0.57–1.31]	1.16	[0.77–1.80]
	High	0.80	[0.49–1.32]	0.97	(0.59–1.64]
All cancers	Reference	1		1
	Medium	0.98	[0.89–1.07]	1.00	[0.91–1.11]
	High	0.90	[0.81–1.01]	1.03	[0.92–1.15]
Lung cancer	Reference	1		1
	Medium	1.02	[0.81–1.29]	0.79	[0.51–1.28]
	High	1.09	[0.84–1.43]	1.05	[0.65–1.78]
Breast cancer	Reference	na	na	1
	Medium	na	na	1.07	[0.91–1.25]
	High	na	na	0.99	[0.82–1.20]
Bladder cancer	Reference	1		1
	Medium	0.83	[0.56–1.26]	1.07	[0.58–2.12]
	High	0.76	[0.48–1.23]	0.81	[0.38–1.70]
Acute leukemia	Reference	1		1
	Medium	1.86	[0.87–4.13]	1.08	[0.38–3.97]
	High	2.57	[1.10–6.33]	0.94	[0.29–4.24]
Myeloma	Reference	1		1
	Medium	1.35	[0.54–3.61]	0.73	[0.32–1.62]
	High	1.65	[0.57–5.07]	0.40	[0.15–1.02]
Malignant non-Hodgkin’s lymphoma	Reference	1		1
	Medium	0.81	[0.52–1.23]	0.88	[0.51–1.59]
	High	0.61	[0.35–1.00]	0.86	[0.47–1.63]

Na: not available.